Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)

Pediatric Blood and Cancer

Volumn 61, Issue 5, 2014, Pages 885-893

  Kaste, S C ^a,b   Qi, A ^a   Smith, K ^a   Surprise, H ^a   Lovorn, E ^a   Boyett, J ^a   Ferry, R J ^b,c   Relling, M V ^a   Shurtleff, S A ^a   Pui, C H ^a   Carbone, L ^b   Hudson, M M ^a   Ness, K K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

ALL; Childhood cancer survivor; Cholecalciferol; Controlled trial; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCIUM CARBONATE; COLECALCIFEROL; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENAL CORTEX DISEASE; ADULT; ARTICLE; BODY MASS; BONE DENSITY; CANCER SURVIVOR; CAUCASIAN; CHILD; CHILDHOOD LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MASCULINITY; NEPHROLITHIASIS; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; YOUNG ADULT;

ALL; CHILDHOOD CANCER SURVIVOR; CHOLECALCIFEROL; CONTROLLED TRIAL; VITAMIN D;

ADOLESCENT; ADULT; BONE DENSITY; CALCIUM, DIETARY; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; COUNSELING; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTERVENTION STUDIES; LUMBAR VERTEBRAE; MALE; NUTRITION THERAPY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84895727358     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24882     Document Type: Article

References (50)

1. Fan C, Foster BK, Wallace WH, et al. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Curr Mol Med 2011; 11:140-151.
2. Georgiou KR, Scherer MA, Fan CM, et al. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow. J Cell Physiol 2012; 227:909-918.
3. Chaiban J, Muwakkit S, Arabi A, et al. Modeling pathways for low bone mass in children with malignancies. J Clin Densitom 2009; 12:441-449.
4. Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int 2000; 11:985-1009.
5. Matkovic V, Jelic T, Wardlaw GM, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994; 93:799-808.
6. Oliver H, Jameson KA, Sayer AA, et al. Growth in early life predicts bone strength in late adulthood: The Hertfordshire Cohort Study. Bone 2007; 41:400-405.
7. Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep 2010; 12:186-191.
8. Rai SN, Hudson MM, McCammon E, et al. Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. Contemp Clin Trials 2008; 29:711-719.
9. Evans WE, Relling MV, Rodman JH, et al. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998; 338:499-505.
10. Kishi S, Griener J, Cheng C, et al. Homocysteine pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003; 21:3084-3091.
11. Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010; 24:371-382.
12. Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 2004; 104:2690-2696.
13. Rivera GK, Pui CH, Santana VM, et al. Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer 1993; 71(Suppl):3400-3405.
14. Rivera GK, Raimondi SC, Hancock ML, et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337:61-66.
15. Hudson MM, Hester A, Sweeney T, et al. A model of care for childhood cancer survivors that facilitates research. J Pediatr Oncol Nurs 2004; 21:170-174.
16. Cann CE. Quantitative CT for determination of bone mineral density: A review. Radiology 1988; 166:509-522.
17. Kaste SC, Tong X, Hendrick JM, et al. QCT versus DXA in 320 survivors of childhood cancer: Association of BMD with fracture history. Pediatr Blood Cancer 2006; 47:936-943.
18. Greulich W, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. Palo Alto, CA: Stanford University Press; 1969.
19. Block G, Woods M, Potosky A, et al. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-1335.
20. Boucher B, Cotterchio M, Kreiger N, et al. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 2006; 9:84-93.
21. Godin G, Jobin J, Bouillon J. Assessment of leisure time exercise behavior by self-report: A concurrent validity study. Can J Public Health 1986; 77:359-362.
22. Tanner JM. The measurement of maturity. Trans Eur Orthod Soc 1975; 45-60.
23. Rayar MS, Nayiager T, Webber CE, et al. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012; 59:77-82.
24. Jones TS, Kaste SC, Liu W, et al. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol 2008; 26:3031-3037.
25. Mitchell BD, Yerges-Armstrong LM. The genetics of bone loss: Challenges and prospects. J Clin Endocrinol Metab 2011; 96:1258-1268.
26. Ralston SH, Uitterlinden AG. Genetics of osteoporosis. Endocr Rev 2010; 31:629-662.
27. te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, et al. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia. Haematologica 2010; 95:752-759.
28. Zheng HF, Spector TD, Richards JB. Insights into the genetics of osteoporosis from recent genome-wide association studies. Expert Rev Mol Med 2011; 13:e28.
29. Callreus M, McGuigan F, Ringsberg K, et al. Self-reported recreational exercise combining regularity and impact is necessary to maximize bone mineral density in young adult women: A population-based study of 1, 061 women 25 years of age. Osteoporos Int 2012; 10:2517-2526.
30. Jarfelt M, Fors H, Lannering B, et al. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 2006; 154:303-309.
31. Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: A 1-year prospective study. Pediatrics 2005; 116:e102-e108.
32. Perez-Lopez FR, Chedraui P, Cuadros-Lopez JL. Bone mass gain during puberty and adolescence: Deconstructing gender characteristics. Curr Med Chem 2010; 17:453-466.
33. Vicente-Rodriguez G. How does exercise affect bone development during growth? Sports Med 2006; 36:561-569.
34. Sonneville KR, Gordon CM, Kocher MS, et al. Vitamin D, calcium, and dairy intakes and stress fractures among female adolescents. Arch Pediatr Adolesc Med 2012; V 7: 595-600.
35. Benmiloud S, Steffens M, Beauloye V, et al. Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood. Horm Res Paediatr 2010; 74:241-250.
36. Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117:238-244.
37. Hoorweg-Nijman JJ, Kardos G, Roos JC, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol 1999; 50:237-244.
38. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001; 15:728-734.
39. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1081-1093.
40. Gunter K, Baxter-Jones AD, Mirwald RL, et al. Impact exercise increases BMC during growth: An 8-year longitudinal study. J Bone Miner Res 2008; 23:986-993.
41. Macdonald HM, Kontulainen SA, Khan KM, et al. Is a school-based physical activity intervention effective for increasing tibial bone strength in boys and girls? J Bone Miner Res 2007; 22:434-446.
42. MacKelvie KJ, Khan KM, Petit MA, et al. A school-based exercise intervention elicits substantial bone health benefits: A 2-year randomized controlled trial in girls. Pediatrics 2003; 112:e447.
43. Maggio AB, Rizzoli RR, Marchand LM, et al. Physical activity increases bone mineral density in children with type 1 diabetes. Med Sci Sports Exerc 2012; 44:1206-1211.
44. Meyer U, Romann M, Zahner L, et al. Effect of a general school-based physical activity intervention on bone mineral content and density: A cluster-randomized controlled trial. Bone 2011; 48:792-797.
45. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to endocrine society vitamin D guideline. J Clin Endocrinol Metab 2012; 97:1146-1152.
46. Skversky AL, Kumar J, Abramowitz MK, et al. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab 2011; 96:3838-3845.
47. Cashman KD, Hill TR, Lucey AJ, et al. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 2008; 88:1535-1542.
48. Diaz PR, Neira LC, Fischer SG, et al. Effect of 1, 25(OH)2-vitamin D on bone mass in children with acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 2008; 30:15-19.
49. Simmons JH, Chow EJ, Koehler E, et al. Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: Treatment with chemotherapy compared with allogeneic stem cell transplant. Pediatr Blood Cancer 2011; 56:1114-1119.
50. Melamed ML, Kumar J. Low levels of 25-hydroxyvitamin D in the pediatric populations: Prevalence and clinical outcomes. Pediatr Health 2010; 4:89-97.